Antioxidant properties of cabergoline: Inhibition of brain auto-oxidation and superoxide anion production of microglial cells in rats

Neuroscience Letters

Volumn 330, Issue 1, 2002, Pages 1-4

  Yoshida, Toshihiko ^a   Tanaka, Makoto ^a   Suzuki, Yoko ^a   Sohmiya, Makoto ^a   Okamoto, Koichi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Tocopherol; 2 Methyl 6 (p methoxyphenyl) 3,7 dihydroimidazo 1, 2 a pyrazin 3 one dependent chemiluminescence assay; Cabergoline; Microglial cells; Opsonized zymosan; Parkinson's disease; Phorbol myristate acetate

Indexed keywords

2 METHYL 6 (4 METHOXYPHENYL) 3,7 DIHYDROIMIDAZO[1,2 A]PYRAZIN 3 ONE; ALPHA TOCOPHEROL; CABERGOLINE; PHORBOL 13 ACETATE 12 MYRISTATE; PYRAZINE DERIVATIVE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOOXIDATION; BRAIN HOMOGENATE; CELL STIMULATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; MICROGLIA; NERVE CELL DEGENERATION; NEUROPROTECTION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; BRAIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOLINES; MALE; MICROGLIA; OXIDATION-REDUCTION; RATS; RATS, WISTAR; SUPEROXIDES; VITAMIN E;

EID: 0037072562     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00594-3     Document Type: Article

References (17)

1. Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 44:1971;276.
2. Colton C.A., Chernyshev O.N., Gilbert D.L., Vitek M.P. Microglial contribution to oxidative stress in Alzheimer's disease. Ann. New York Acad. Sci. 899:2000;292-307.
3. 14C-cabergoline in the rat brain. Pharmacol. Res. 35:1997;202.
4. Ebadi M., Srinivasan S.K., Baxi M.D. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 22:1996;1-19.
5. Finotti N., Castagna L., Moretti A., Marzatico F. Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment. Pharmacol. Res. 42:2000;287-291.
6. Gotoh Y., Miyagi M., Nakamura S., Nishiyama M., Ujiie A. Studies on the metabolic fate of cabergoline (III): identification of liver metabolites, distribution of brain, and effect on hepatic drug-metabolizing enzymes in rats. Yakubutudoutai. 11:1996;358-368.
7. Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., Czlonkowska A. MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease. Acta Neurobiol. Exp. 59:1999;1-8.
8. Mehrdad R., Gila B. Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence. Brain Res. 892:2001;211-217.
9. -. Anal. Biochem. 159:1986;363-369.
10. Nishibayashi S., Asanuma M., Kohno M., Gomez-Vargas M., Ogawa N. Scavenging effects of dopamine agonists on nitric oxide radicals. J. Neurochem. 67:1996;2208-2211.
11. -. Clin. Chim. Acta. 179:1989;177-181.
12. Ogawa N., Tanaka K., Asanuma M., Kawai M., Masumizu T., Kohno M., Mori A. Bromocriptine protects mice against 6-hydroxydopamine and scavengers hydroxyl free radical in vitro. Brain Res. 657:1994;207-213.
13. Tanaka M., Sotomatsu A., Yoshida T., Hirai S., Nishida A. Detection of superoxide production by activated microglia using a sensitive and specific chemiluminescence assay and microglia-mediated PC12h cell death. J. Neurochem. 63:1994;266-270.
14. Tanaka M., Sotomatsu A., Yoshida T., Hirai S. Inhibitory effects of bromocriptine on phospholipid peroxidation induced by DOPA and iron. Neurosci. Lett. 183:1995;116-119.
15. Van Muiswinkle F.L., Veerhuis R., Eikelenboom P. Amyloid β protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J. Neurochem. 66:1996;2468-2476.
16. Yoshida T., Tanaka M., Sotomatsu A., Okamoto K. Activated microglia cause iron-dependent lipid peroxidation in the presence of ferritin. NeuroReport. 9:1998;1929-1933.
17. Yoshida T., Tanaka M., Okamoto K. Inhibitory effect of nicergoline on superoxide generation by activated rat microglias measured using a simple chemiluminescence method. Neurosci. Lett. 297:2001;5-8.